337 related articles for article (PubMed ID: 17504985)
1. Tissue factor expression, angiogenesis, and thrombosis in pancreatic cancer.
Khorana AA; Ahrendt SA; Ryan CK; Francis CW; Hruban RH; Hu YC; Hostetter G; Harvey J; Taubman MB
Clin Cancer Res; 2007 May; 13(10):2870-5. PubMed ID: 17504985
[TBL] [Abstract][Full Text] [Related]
2. Tissue factor expression correlates with tumor angiogenesis and invasiveness in human hepatocellular carcinoma.
Poon RT; Lau CP; Ho JW; Yu WC; Fan ST; Wong J
Clin Cancer Res; 2003 Nov; 9(14):5339-45. PubMed ID: 14614019
[TBL] [Abstract][Full Text] [Related]
3. Tissue factor and VEGF expression in prostate carcinoma: a tissue microarray study.
Yao JL; Ryan CK; Francis CW; Kohli M; Taubman MB; Khorana AA
Cancer Invest; 2009 May; 27(4):430-4. PubMed ID: 19219655
[TBL] [Abstract][Full Text] [Related]
4. [Correlation of tissue factor expression to angiogenesis of gastric carcinoma and its clinical significance].
Jiao ZY; Gou CZ; Cao N; Li YM
Ai Zheng; 2005 Jul; 24(7):880-4. PubMed ID: 16004820
[TBL] [Abstract][Full Text] [Related]
5. Effect of endothelial PAS domain protein 1 and hypoxia inducible factor 1alpha on vascular endothelial growth factor expression in human pancreatic carcinoma.
Zhu DM; Li DC; Zhang ZX; Zhang XY
Chin Med J (Engl); 2008 Nov; 121(22):2258-64. PubMed ID: 19080330
[TBL] [Abstract][Full Text] [Related]
6. Expression of tissue factor is associated with clinical features and angiogenesis in prostate cancer.
Ohta S; Wada H; Nakazaki T; Maeda Y; Nobori T; Shiku H; Nakamura S; Nagakawa O; Furuya Y; Fuse H
Anticancer Res; 2002; 22(5):2991-6. PubMed ID: 12530031
[TBL] [Abstract][Full Text] [Related]
7. Alternatively spliced human tissue factor promotes tumor growth and angiogenesis in a pancreatic cancer tumor model.
Hobbs JE; Zakarija A; Cundiff DL; Doll JA; Hymen E; Cornwell M; Crawford SE; Liu N; Signaevsky M; Soff GA
Thromb Res; 2007; 120 Suppl 2():S13-21. PubMed ID: 18023707
[TBL] [Abstract][Full Text] [Related]
8. Tissue factor expression and angiogenesis in human prostate carcinoma.
Abdulkadir SA; Carvalhal GF; Kaleem Z; Kisiel W; Humphrey PA; Catalona WJ; Milbrandt J
Hum Pathol; 2000 Apr; 31(4):443-7. PubMed ID: 10821491
[TBL] [Abstract][Full Text] [Related]
9. Analysis of combination anti-angiogenesis therapy on markers of coagulation, platelet activation and angiogenesis in patients with advanced cancer.
Caine GJ; Harris AL; Christodoulos K; Lip GY; Blann AD
Cancer Lett; 2005 Mar; 219(2):163-7. PubMed ID: 15723715
[TBL] [Abstract][Full Text] [Related]
10. Prognosis in human melanoma: PAR-1 expression is superior to other coagulation components and VEGF.
Depasquale I; Thompson WD
Histopathology; 2008 Mar; 52(4):500-9. PubMed ID: 18315603
[TBL] [Abstract][Full Text] [Related]
11. Tissue factor and fibrin in tumor angiogenesis.
Fernandez PM; Patierno SR; Rickles FR
Semin Thromb Hemost; 2004 Feb; 30(1):31-44. PubMed ID: 15034796
[TBL] [Abstract][Full Text] [Related]
12. Tissue factor and vascular endothelial growth factor expression in colorectal cancer: relation with cancer recurrence.
Altomare DF; Rotelli MT; Pentimone A; Rossiello MR; Martinelli E; Guglielmi A; De Fazio M; Marino F; Memeo V; Colucci M; Semeraro N
Colorectal Dis; 2007 Feb; 9(2):133-8. PubMed ID: 17223937
[TBL] [Abstract][Full Text] [Related]
13. Oncogenes as regulators of tissue factor expression in cancer: implications for tumor angiogenesis and anti-cancer therapy.
Yu JL; May L; Klement P; Weitz JI; Rak J
Semin Thromb Hemost; 2004 Feb; 30(1):21-30. PubMed ID: 15034795
[TBL] [Abstract][Full Text] [Related]
14. The angiogenic switch occurs at the adenoma stage of the adenoma carcinoma sequence in colorectal cancer.
Staton CA; Chetwood AS; Cameron IC; Cross SS; Brown NJ; Reed MW
Gut; 2007 Oct; 56(10):1426-32. PubMed ID: 17566019
[TBL] [Abstract][Full Text] [Related]
15. Inverse prognostic impact of angiogenic marker expression in tumor cells versus stromal cells in non small cell lung cancer.
Donnem T; Al-Saad S; Al-Shibli K; Delghandi MP; Persson M; Nilsen MN; Busund LT; Bremnes RM
Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6649-57. PubMed ID: 18006765
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical evaluation of the tumor neoangiogenesis as a prognostic factor for gastric cancers.
Lazăr D; Tăban S; Raica M; Sporea I; Cornianu M; Goldiş A; Vernic C
Rom J Morphol Embryol; 2008; 49(2):137-48. PubMed ID: 18516318
[TBL] [Abstract][Full Text] [Related]
17. High-grade clear cell renal cell carcinoma has a higher angiogenic activity than low-grade renal cell carcinoma based on histomorphological quantification and qRT-PCR mRNA expression profile.
Baldewijns MM; Thijssen VL; Van den Eynden GG; Van Laere SJ; Bluekens AM; Roskams T; van Poppel H; De Bruïne AP; Griffioen AW; Vermeulen PB
Br J Cancer; 2007 Jun; 96(12):1888-95. PubMed ID: 17505508
[TBL] [Abstract][Full Text] [Related]
18. Circulating endothelial cells in cancer patients do not express tissue factor.
Beerepoot LV; Mehra N; Linschoten F; Jorna AS; Lisman T; Verheul HM; Voest EE
Cancer Lett; 2004 Sep; 213(2):241-8. PubMed ID: 15327840
[TBL] [Abstract][Full Text] [Related]
19. Circulating microparticle tissue factor, thromboembolism and survival in pancreaticobiliary cancers.
Bharthuar A; Khorana AA; Hutson A; Wang JG; Key NS; Mackman N; Iyer RV
Thromb Res; 2013 Aug; 132(2):180-4. PubMed ID: 23856554
[TBL] [Abstract][Full Text] [Related]
20. Microparticle-associated tissue factor activity in patients with pancreatic cancer: correlation with clinicopathological features.
Thaler J; Ay C; Mackman N; Metz-Schimmerl S; Stift J; Kaider A; Müllauer L; Gnant M; Scheithauer W; Pabinger I
Eur J Clin Invest; 2013 Mar; 43(3):277-85. PubMed ID: 23398637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
